In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases - Wikidata - awgldk - TriplyDB

In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases

In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases

http://www.wikidata.org/entity/Q24530443

about

Sporothrix schenckii and Sporotrichosis Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest.Genetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis.Sporotrichosis: an overview and therapeutic options In vitro photodynamic inactivation of Sporothrix schenckii complex species.Morphological and physiological comparison of taxa comprising the Sporothrix schenckii complex Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods.In vitro susceptibility of Sporothrix brasiliensis: Comparison of yeast and mycelial phases.Refractory sporotrichosis due to Sporothrix brasiliensis in humans appears to be unrelated to in vivo resistance.Sporothrix schenckii complex in Iran: Molecular identification and antifungal susceptibility.In vitro antifungal susceptibilities of five species of sporothrix Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis Sporothrix luriei: a rare fungus from clinical origin.

P2860

Q24635012-E083F61C-9736-4EC8-99A7-4B7CBA843922 Q31121317-EE68C7F2-B8BF-4914-A8BE-6F59CB675995 Q33611290-283C3939-B39A-4504-B787-8ACC765FC54B Q34968193-BA63C24F-1E74-4DA6-8E03-7571F45225D6 Q35210755-89450670-5DAF-4664-A2A6-CF0E1B89F634 Q35832498-18242FDC-BE7B-47AE-AB78-636695BB5368 Q38663717-7D22506F-50CF-44A8-8284-C91C16E2A089 Q38803958-9E91CCFC-3C87-46B4-A7F6-D68A5BFF3443 Q39258185-AEC5BDE2-5E4D-416A-811C-B715242ED450 Q40770921-4BD6A52D-97DC-4315-A62E-DF4DBD8381BC Q41915091-D4FAA514-BC9D-4184-926C-8083FF08A8A8 Q41931602-C74DFD78-FD91-4469-B2E8-4B536827F692 Q43583038-ED7BF611-E8B6-444B-A94C-ED544313CEFC

P2860

In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases

http://www.wikidata.org/entity/Q24530443

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases

@ast

In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases

@en

In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases

@nl

type

label

In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases

@ast

In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases

@en

In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases

@nl

prefLabel

In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases

@ast

In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases

@en

In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases

@nl

P1433

Q24530443-D4F40A59-41D0-4EE9-84F8-6D0CE5E382D3

P1476

Q24530443-53279899-F457-42B0-A5E9-BA8576BED1FF

P2093

Q24530443-043CE0CD-482D-4DE3-BF08-1A0D427247EB

Q24530443-3CE5DB0B-430B-4472-BADE-ABA15D841934

Q24530443-53FA67A6-946D-4F11-ACB5-BD6515CFBEFE

Q24530443-7652C2ED-00C4-494C-BF83-800F16C5CC9F

Q24530443-D38D4EA2-A134-425C-A484-654D8D91911A

Q24530443-DE840EB4-FC2D-49DF-AA7F-27F0089384CA

Q24530443-F565865B-FCF6-42A2-9E20-0EBA70086A72

P2860

Q24530443-1941B7D9-BAA6-4457-BE50-EF46D78B2858

Q24530443-1EDF795D-425C-408E-A421-A5F5EB571C12

Q24530443-210653AA-2A01-43AF-8863-657E574FA0CD

Q24530443-2D16DE32-252F-4AEE-83B0-F7B9E0FFE0C3

Q24530443-3D7C13B6-FAC0-4785-A93F-5E974E39245F

Q24530443-3E036FDE-F528-48C9-8865-2BCC7799D02D

Q24530443-48257A57-9BB6-4043-BE5D-20CB3FB1AD40

Q24530443-50AFD52E-565A-43B6-81E8-0F3C28A4A813

Q24530443-7130A3CA-1258-40EA-92BB-D8181FFFAD13

Q24530443-7562E3C5-C793-4435-88AA-0B2605F7101E

P304

Q24530443-C6DF7D25-881B-49AF-857A-8A65D32A2739

P31

Q24530443-EE73EE37-E4B8-46D9-842F-E8AC92A0CF3C

P356

Q24530443-C01B228F-46CD-4D5E-8A7A-F37575E28D6C

P407

Q24530443-76680BF9-547D-4A72-956F-3DA5FC084D95

P433

Q24530443-D189D79F-0D21-4111-9614-D00D5AAAD752

P478

Q24530443-0B23719B-7753-483B-B199-B8593A62AF06

P50

Q24530443-E538E965-D252-4AAA-9FBD-757E103F79CE

P577

Q24530443-67319417-88C4-49CF-B4BB-ED1FB814EC50

P698

Q24530443-73C0DAFC-60AB-44EE-8643-C964017B7C23

P921

Q24530443-F5AF38EC-56A6-44CF-B7FD-82748E871667

P932

Q24530443-E6168E85-FCE8-419E-851E-C52D55381763

P356

AAC.49.9.3952-3954.2005

P1433

Antimicrobial Agents and Chemotherapy

P1476

In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases

@en

P2093

Armando de Oliveira Schubach

http://www.w3.org/2001/XMLSchema#string

Belkys Fernández-Torres

http://www.w3.org/2001/XMLSchema#string

Bodo Wanke

http://www.w3.org/2001/XMLSchema#string

Isabel Inza

http://www.w3.org/2001/XMLSchema#string

Luciana Trilles

http://www.w3.org/2001/XMLSchema#string

Márcia Dos Santos Lazéra

http://www.w3.org/2001/XMLSchema#string

Rodrigo de Almeida Paes

http://www.w3.org/2001/XMLSchema#string

P2860

Endemic mycoses: a treatment update

In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi

Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis.

[A case of lymphocutaneous sporotrichosis].

In vitro antifungal susceptibility of Cryptococcus gattii.

Epidemiology of sporotrichosis in Latin America.

In vitro antifungal activity of Micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms.

In vitro susceptibilities of isolates of Sporothrix schenckii to itraconazole and terbinafine.

In vitro activities of the new antifungal drug eberconazole and three other topical agents against 200 strains of dermatophytes.

Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America.

P304

3952-3954

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.49.9.3952-3954.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16127080

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

P932

1195444

http://www.w3.org/2001/XMLSchema#string